Cargando…
HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis
BACKGROUND: Several studies demonstrated a connection between human leukocyte antigen (HLA)-B∗1502 and lamotrigine (LTG)-induced cutaneous adverse drug reactions (cADRs). The correlation between the HLA-A∗24:02 and LTG-cADRs remains controversial. To examine the associations between HLA-A∗24:02 and...
Autores principales: | Li, Wanshu, Wang, Jie, Lin, Hangjuan, Shen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769343/ https://www.ncbi.nlm.nih.gov/pubmed/33350798 http://dx.doi.org/10.1097/MD.0000000000023929 |
Ejemplares similares
-
Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
por: Koomdee, Napatrupron, et al.
Publicado: (2017) -
HLA-A*24:02 as a common risk factor for antiepileptic drug–induced cutaneous adverse reactions
por: Shi, Yi-Wu, et al.
Publicado: (2017) -
HLA-B*15:02 genotype associated with hypersensitivity syndrome to lamotrigine in Thai population
por: Koomdee, Napatrupron, et al.
Publicado: (2014) -
Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions – a review of spontaneous reports
por: Brickel, Neil, et al.
Publicado: (2017) -
Cutaneous Adverse Drug Reactions to Lamotrigine and Human Leukocyte Antigen Typing in North Indian Patients: A Case Series
por: Srivastava, Shivani, et al.
Publicado: (2017)